Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors

Pathology Research and Practice

Volumn 205, Issue 5, 2009, Pages 339-345

  Kalinski, Thomas ^a   Sel, Saadettin ^b   Kouznetsova, Irina ^a   Röpke, Martin ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Angiogenesis; Chondrosarcoma; Enchondroma; Endothelial cell proliferation; Pericyte coverage

Indexed keywords

VASCULOTROPIN A;

ARTICLE; CANCER GRADING; CARTILAGE TUMOR; CELL PROLIFERATION; CHONDROSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENCHONDROMA; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPIC VARIATION; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

BONE NEOPLASMS; CELL PROLIFERATION; CHONDROMA; CHONDROSARCOMA; ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES;

EID: 64449086897     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.12.008     Document Type: Article

References (28)

1. Ayala G., Liu C., Nicosia R., Horowitz S., and Lackman R. Microvasculature and VEGF expression in cartilaginous tumors. Hum. Pathol. 31 (2000) 341-346
2. Batist G., Patenaude F., Champagne P., Croteau D., Levinton C., Hariton C., Escudier B., and Dupont E. Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Ann. Oncol. 13 (2002) 1259-1263
3. Bonnet C.S., and Walsh D.A. Osteoarthritis, angiogenesis and inflammation. Rheumatology 44 (2005) 7-16
4. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
5. Cursiefen C., Hofmann-Rummelt C., Küchle M., and Schlötzer-Schrehardt U. Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation. Br. J. Ophthalmol. 87 (2003) 101-106
6. Eberhard A., Kahlert S., Goede V., Hemmerlein B., Plate K.H., and Augustin H.G. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 60 (2000) 1388-1393
7. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974
8. Fox S.B. Tumour angiogenesis and prognosis. Histopathology 30 (1997) 294-301
9. Fukumura D., and Jain R.K. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc. Res. 74 (2007) 72-84
10. M.S. Gee, W.N. Procopio, S. Makonnen, M.D. Feldman, N.M. Yeilding, W.M. Lee, Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy, Am. J. Pathol. 162, pp. 183-193.
11. Gingras D., Renaud A., Mousseau N., and Béliveau R. Shark cartilage extracts as antiangiogenic agents: smart drinks or bitter pills?. Cancer Metastasis Rev. 19 (2000) 83-86
12. Hicklin D.J., and Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23 (2005) 1011-1027
13. Hlatky L., Hahnfeldt P., and Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J. Natl. Cancer Inst. 94 12 (2002) 883-893
14. Hoffmann J., Feng Y., vom Hagen F., Hillenbrand A., Lin J., Erber R., Vajkoczy P., Gourzoulidou E., Waldmann H., Giannis A., Wolburg H., Shani M., Jaeger V., Weich H.A., Preissner K.T., Hoffmann S., Deutsch U., and Hammes H.P. Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. FASEB J. 19 (2005) 2035-2036
15. Hofstaetter J.G., Wunderlich L., Samuel R.E., Saad F.A., Choi Y.H., and Glimcher M.J. Systemic hypoxia alters gene expression levels of structural proteins and growth factors in knee joint cartilage. Biochem. Biophys. Res. Commun. 330 (2005) 386-394
16. Kalinski T., Krueger S., Sel S., Werner K., Ropke M., and Roessner A. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta. Cancer 106 (2006) 2028-2038
17. Kalinski T., Krueger S., Sel S., Werner K., Röpke M., and Roessner A. ADAMTS1 is regulated by interleukin-1beta, not by hypoxia, in chondrosarcoma. Hum. Pathol. 38 (2007) 86-94
18. Latreille J., Batist G., Laberge F., Champagne P., Croteau D., Falardeau P., Levinton C., Hariton C., Evans W.K., and Dupont E. Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer. Clin. Lung Cancer 4 (2003) 231-236
19. Lin C., McGough R., Aswad B., Block J.A., and Terek R. Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J. Orthop. Res. 22 (2004) 1175-1181
20. Loprinzi C.L., Levitt R., Barton D.L., Sloan J.A., Atherton P.J., Smith D.J., Dakhil S.R., Moore Jr. D.F., Krook J.E., Rowland Jr. K.W., Mazurczak M.A., Berg A.R., and Kim G.P. North central cancer treatment group. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer 104 (2005) 176-182
21. McGough R.L., Aswad B.I., and Terek R.M. Pathologic neovascularization in cartilage tumors. Clin. Orthop. Relat. Res. 397 (2002) 76-82
22. Morikawa S., Baluk P., Kaidoh T., Haskell A., Jain R.K., and McDonald D.M. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160 (2002) 985-1000
23. Ozerdem U., and Stallcup W.B. Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 6 (2003) 241-249
24. Pang R.W., and Poon R.T. Clinical implications of angiogenesis in cancers. Vasc. Health Risk Manag. 2 (2006) 97-108
25. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., and Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15 (2001) 2865-2876
26. Uemura A., Ogawa M., Hirashima M., Fujiwara T., Koyama S., Takagi H., Honda Y., Wiegand S.J., Yancopoulos G.D., and Nishikawa S. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110 (2002) 1619-1628
27. Verheul H.M., Voest E.E., and Schlingemann R.O. Are tumours angiogenesis-dependent?. J. Pathol. 202 (2004) 5-13
28. Yonenaga Y., Mori A., Onodera H., Yasuda S., Oe H., Fujimoto A., Tachibana T., and Imamura M. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 69 (2005) 159-166